Pharma Faces: Demet Russ, Janssen Turkey
After an international career spanning 25 years, Demet Russ returned to her native Turkey to lead the Janssen affiliate during a tumultuous time and is aiming to give back to…
Address: Barbaros Bulvari Morbasan sok. Koza Is Merkezi B Blok Kat 3; 34349 Balmumcu Besiktas / Istanbul / Turkey
Tel: +90 212 272 5094
Web: http://www.yased.org.tr/webportal/English/Pages/MainPage.aspx
YASED, International Investors Association of Turkey, founded in 1980, is a non-profit, private sector organization whose members are international companies operating in Turkey. Being the most important representative of the international direct investments in Turkey, YASED members share a common vision and work proactively to promote a better business environment.
YASED undertakes the responsibility for and works towards “Establishing International Standards and Best Practices”, “Ensuring the Support of Public Opinion for International Investments” and “Improving the Perception of Turkey as an Attraction Center for Investments” with its accumulated know-how, experience and relationship network.
They promote networking and communication between established, new and potential investors, facilitating the exchange of information and specifically foster better communication with YASED members. The Association acts as a platform for new ideas and provides collective support to their members in their dealings with Turkish governmental and regulatory bodies on business issues of common interest.
After an international career spanning 25 years, Demet Russ returned to her native Turkey to lead the Janssen affiliate during a tumultuous time and is aiming to give back to…
Avinash Potnis of Novartis Turkey discusses potential solutions to the country’s access and pricing dilemma which has raised concerns of system sustainability. Potnis also highlights the strengths of Turkey’s healthcare…
Ingrid Drechsel, head of Bayer’s pharma operations in Turkey and Iran, discusses the complexity of managing two countries under economic pressure and the advantages of Bayer’s longstanding relationship in both…
Menarini’s general manager for Turkey, the Middle East and Africa Uğur Bingöl discusses the Italian company’s restructuring in the region and its desire to replicate its success in Turkey across…
The secretary general for Turkey’s Pharmaceutical Manufacturers Association (IEIS), Savaş Malkoç, highlights their objective of increasing R&D expenditure and Turkey’s big opportunity ahead in biosimilars production. In addition, Malkoç discusses…
Janssen’s Managing Director for Turkey, Demet Russ, discusses her return to the country after 25 years abroad, having worked for Johnson & Johnson in different local, regional and global roles…
As one of the leading pharma companies in Turkey, DEVA is pioneering a new approach to generics in the country. Chairman of the Board and CEO Philipp Haas discusses the…
As COVID-19 began spreading through the world, the race to understand the disease by scientists and doctors took off. After just a few months, it became apparent that people with…
The president of the Turkish Society of Cardiology, Mustafa Kemal Erol, discusses the prevalence of cardiovascular disease, which accounts for over a third of deaths in Turkey, the improvements made…
AmCham Turkey’s executive director, Asli Özelli, examines the impact of US companies on the Turkish economy with over USD 50 billion in investment, their help during the pandemic, the chamber’s…
Dr Burak Cem, Novo Nordisk Vice President and General Manager for Turkey, outlines the company’s big bet on Turkey as a future regional hub through deep investment in clinical trials,…
Turkey’s former Minister of Health, Bülent Akarcali, outlines the country’s healthcare system evolution over the past decades, comparing the improvements to the difference between a Ford Model T to a…
See our Cookie Privacy Policy Here
